Evidence is presented for the specific in vivo and in vitro inhibition of isovaleryl CoA dehydrogenation by hypoglycin A and its derivative, a-ketomethylenecyclopropylpropionic acid. a-Methylbutyryl
Isovaleric acidemia is a genetic defect of leucine metabolism (1) (2) (3) (4) in which isovaleric acid accumulates in blood in large amounts. Based on the biochemical findings in this hereditary disorder, we proposed that isovaleryl CoA is dehydrogenated by a specific enzyme, isovaleryl CoA dehydrogenase (1, 3) and that this enzyme is deficient in patients with isovaleric acidemia ( Fig. 1) . It was previously believed that isovaleryl CoA, butyryl CoA, and hexanoyl CoA were dehydrogenated by a single enzyme, acyl CoA dehydrogenase (5, 6) .
It has subsequently been shown that oxidation of leucine is inhibited by hypoglycin A (7, 8) . In contrast, oxidation of valine and isoleucine are not significantly inhibited by this compound (8) . However, the specific step in the pathway of leucine metabolism that is inhibited by hypoglycin A has not been precisely identified.
Hypoglycin A is an unusual amino acid having the structure of a-aminomethylenecyclopropylpropionic acid (9) . It has been extracted from unripe fruits of ackee grown in Jamaica and has been identified as the cause of the "vomiting sickness of Jamaica" (10) . Extreme hypoglycemia (11) and depletion of liver glycogen (12) have been observed in the cases of this disease. These same in vivo effects have been observed in experimental animals after injection of hypoglycin A (13, 14) . Several groups of investigators subsequently concluded that the hypoglycemia and depletion of glycogen were due to the decreased gluconeogenesis resulting from impairment of long chain fatty acid metabolism (15) (16) (17) . In these studies, (Fig. 2) . The radioactivity peak of the product corresponded with that of unlabeled iVGly (assessed by titration). Much less radioactivity was observed around the region of iVGly in the same chromatographic system from an incubation medium without inhibitor. Therefore, the fractions of the main radioactive peak for each sample were combined and the product was recrystallized several times ( Table 2 ). The iVGly crystals from the incubation medium with the inhibitor showed a constant, high specific activity through four recrystallizations. In contrast, almost all of the radioactivity of the control was lost in the mother liquor from the first recrystallization, and the specific activity in the iVGly crystals decreased with each subsequent recrystallization. In a subsequent experiment, it was Each incubation mixture contained liver slices (about 100 mg) in 2 ml of Krebs-Ringer bicarbonate buffer containing 5.6 jsmol glucose.
The amount of the substrate was 1.5 lsmol (1 1sCi). Results are expressed as the mean ± standard error of four experiments. Numbers marked are significantly different from corresponding controls: * P < 0.001; t P < 0.005, as appraised by Student's t test. confirmed by GLC, that the iVGly fraction was highly labeled in the four incubations containing KMCPP, whereas radioactivity of this fraction was very low in the control group (Fig.  3) . 3. Demonstration of Radioactivity in the Isovaleryl Moiety of iVGly. Incorporation of 14C into the isovaleric acid moiety was confirmed by GLC of short-chain fatty acids after acid hydrolysis. As shown in Table 3 , most of the radioactivity was found in the isovaleric-acid fraction in the samples from incubations containing KMCPP. Very little label was found in this fraction in the control group. Essentially no activity was found in the j3-methylcrotonic acid fraction in either group. 4 One-half of each sample from tubes 7-11 of Fig. 2 were combined. 10 mg of iVGly was added before the first recrystallization.
[14CIC02 productionwas inhibited 60% with 2.1 mrNI K TMCPP, but radioactivity did not increase significantly in the steamdistillable fractions. By GLC it was found that '4C-incorporatiol) into isobutyric acid was not significantly different from control incubations (Table 3) . KMCPP showed inhibitory effects (20%) on isoleucine oxidation at a concentration of 2.1 mMA. Analysis of the incubation by GLC showed accumulation of labeled a-methylbutyrate (Table 3) . corresponding controls: *P < 0.001 (see Table 1 ). t P < 0.001; t a-methylbutyrate.
Comparison of inhibitory effect of hypoglycin A and 4-PE in vitro was made using uniformly labeled ileucine, L-isoleucine, and L-valine. Hypoglycin A (1.4 mM) inhibited [14C1C02 production from L-leucine most strongly. i-Isoleucine oxidation was inhibited less, while L-valine oxidation was unaffected. In contrast, 4-PE, up to 4.2 mMA, did not inhibit leucine oxidation significantly. The administration of each amino acid to rats at a dose of 60 mg per 100 g of body weight resulted in no significant increase of the corresponding short-chain fatty acid in the plasma. However, when hypoglycin A was given (10 mg per 100 g of body weight) 30 min before ileucine, the plasma content of a branched-chain pentanoic acid increased up to 200 times that of the control group (Table 4) . In a second control group that was given only hypoglycin A, the same branched-chain pentanoic acid increased 45-fold. The product was identified as isovaleric acid on a DOP-PA column (1).
When isoleucine was given after hypoglycin A administration, a branched-chain pentanoic acid increased 30-fold. By the use of a DOP-PA column, this peak was identified as amethylbutyric acid (1). In both the leucine and isoleucine experiments, there was also some increase in plasma n-butyric acid. Note that in the L-valine-hypoglycin group, in which isobutyric acid should have increased if the same kind of inhibition had occurred, no significant increase in isobutyric acid was found.
When these experiments were carried out using 4-PE as an inhibitor (30 mg per 100 g of body weight), followed by ileucine administration, no significant increase in plasma isovaleric acid was observed (Table 4) .
DISCUSSION
The acctumulation of N-isovalerylglycine in the medium when liver slices were incubated with [2- Bressler and co-workers have suggested that the inhibition of long chain fatty acid oxidation by methylenecyclopropylacetic acid and 4-PE is due to the ability of these inhibitors to form nonmetabolizable esters with CoA and (-)-carnitine (17, 20) . As a result, free CoA and (-)-carnitine become less available. Since (-)-carnitine is necessary for the oxidation of long-chain fatty acids in mitochondria, but not for shortchain fatty acid oxidation, this has been proposed as the basis for the specific inhibition of long-chain fatty acid oxidation while short chain fatty acid oxidation remains unaltered (21) .
Methvlenecyclopropylacetic acid and 4-PE share two chemical structures in common, namely a five-carbon chain and a vinyl group separated by two carbons from the carboxyl group. These structures are believed to be necessary for their hypoglycemic action (9) and, also, for their inhibition of long-chain fatty acid oxidation (17, 20) . However, there is a striking difference in the structure of these two compounds, namely the presence of the cyclopropane ring. The inhibitory effect of hvpoglycin A on isovaleryl CoA dehydrogenase apVol. 68, 1971 pears to be, in part, due to the presence of a cyclopropane ring since 4-PE failed to show this action. In our preliminary experiments, cyclopropane carboxylic acid, which is analogous to isobutyric acid, only slightly inhibited dehydrogenation of isobutyric acid in vivo. It appears, therefore, that the methylenecyclopropane group is responsible for the inhibition of isovaleryl CoA dehydrogenation.
The inhibition of isovaleryl CoA dehydrogenase by hypoglycin A has important clinical implications. One of these is the experimental production of isovaleric acidemia. In addition, the present findings provide a pathophysiological explanation for some of the symptoms of the "vomiting sickness of Jamaica." In this disease, profound hypoglycemia occurs following the ingestion of unripe ackee fruit; the hypoglycemia has been attributed to ingested hypoglycin A. Some of the patients with this disorder die in spite of glucose infusions. This lack of response has been attributed to irreversible brain damage occurring during the duration of hypoglycemia prior to the glucose infusions (11, 12) . However, it would appear that increased concentrations of isovaleric acid induced by the ingested hypoglycin A probably account for some of these observations. Congenital isovaleric acidemia is sometimes fatal (4) . It is also noteworthy that when cats and dogs are given hypoglycin A, they manifest symptoms similar to those found in isovaleric acidemia (depression, vomiting, and ataxia) without any significant hypoglycemia (13) .
